Aphria Deutschland
Manufacturing · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Isarstraãÿe 17, 24539, GermanyWebsite
www.aphria.deRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Aphria Deutschland
Tilray Deutschland is a leading company in the research, production, and distribution of medical cannabis. The company aims to improve the quality of life for patients experiencing discomfort despite traditional therapies and aspires to be the most trustworthy provider of medical cannabis. It exports medical cannabis to 20 countries across five continents, catering to hundreds of thousands of patients, doctors, pharmacies, hospitals, authorities, and researchers, particularly in the European Union, Canada, Australia, and Latin America. Tilray collaborates with medical professionals and universities to advance the therapeutic applications of cannabinoids.Explore more
Popular SearchesAphria DeutschlandAphria Deutschland GmbHSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aphria Deutschland your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Aphria Deutschland has new funding data
Check out if Aphria Deutschland is spiking on competitors!
Click to see if Aphria Deutschland had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Aphria Deutschland has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aphria Deutschland recently announced quarterly report
Product Launch: Get notified when Aphria Deutschland launches new products
Aphria Deutschland, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Aphria Deutschland
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Aphria Deutschland is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aphria Deutschland is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aphria Deutschland.
Aphria Deutschland Tech Stack
A closer look at the technologies used by Aphria Deutschland
Aphria Deutschland News & Media
Aphria RX GmbH, filiale de Tilray, finalise la première récolte et livraison de cannabis médical cultivé en Allemagne
NEW YORK & NEUMÜNSTER, Allemagne--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ | TSX: TLRY), pionnier mondial dans les domaines de la recherche, la culture, la production et la distribution de cannabis, a annoncé aujourd'hui que sa filiale détenue en exclusivité en Allemagne, Aphria RX GmbH, a finalisé avec succès sa première récolte de cannabis thérapeutique cultivé en Allemagne, en vue de sa distribution à des pharmacies allemandes. Cette récolte est la première de cannabis médical cultivé conformémDochteronderneming Aphria RX GmbH van Tilray voltooit eerste succesvolle oogst en levering van medicinale cannabis geteeld in Duitsland
NEW YORK & NEUMÜNSTER, Duitsland--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ | TSX: TLRY), een wereldwijde pionier op het gebied van onderzoek, teelt, productie en distributie van cannabis, heeft vandaag aangekondigd dat zijn volledige dochteronderneming in Duitsland, Aphria RX GmbH, de eerste succesvolle oogst van in Duitsland geteelde medicinale cannabis heeft afgerond voor distributie aan Duitse apotheken. De oogst van medicinale cannabis is de eerste die is geteeld volgens de Europese Good ManufTilrays Tochtergesellschaft Aphria RX GmbH vollendet erste erfolgreiche Ernte und Lieferung von in Deutschland angebautem medizinischem Cannabis
NEW YORK & NEUMÜNSTER, Deutschland--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ | TSX: TLRY), ein globaler Vorreiter in der Cannabisforschung sowie dem Anbau, der Produktion und dem Vertrieb von Cannabis, gab heute bekannt, dass seine hundertprozentige Tochtergesellschaft in Deutschland, Aphria RX GmbH, die erste erfolgreiche Ernte von in Deutschland angebautem medizinischem Cannabis für den Vertrieb an deutsche Apotheken abgeschlossen hat. Die Ernte von medizinischem Cannabis ist die erste, die unteLa filiale Aphria RX GmbH di Tilray completa con successo il primo raccolto e la consegna di cannabis medica coltivata in Germania
NEW YORK & NEUMÜNSTER, Germania--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ | TSX: TLRY), un pioniere globale nella ricerca, coltivazione, produzione e distribuzione della cannabis, ha annunciato oggi che la sua filiale interamente controllata in Germania, Aphria RX GmbH, ha completato con successo il primo raccolto di cannabis medica coltivata in Germania per la distribuzione alle farmacie tedesche. Il raccolto di cannabis medica è il primo coltivato secondo gli standard delle European Good Manufac
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aphria Deutschland
Sign Up For FreeTo access detailed company insights
Tilray Deutschland is a leading company in the research, production, and distribution of medical cannabis. The company aims to improve the quality of life for patients experiencing discomfort despite traditional therapies and aspires to be the most trustworthy provider of medical cannabis. It exports medical cannabis to 20 countries across five con... Read More
